Published online January 4, 2006
PEDIATRICS Vol. 117 No. 1 January 2006, pp. 84-92 (doi:10.1542/peds.2004-2292)
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Web of Science (62)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Benjamin, D. K.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Benjamin, D. K., Jr
Related Collections
Right arrow Infectious Disease & Immunity
Right arrowRelated AAP Red Book topics:
Candidiasis (Moniliasis, Thrush)
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

ARTICLE

Neonatal Candidiasis Among Extremely Low Birth Weight Infants: Risk Factors, Mortality Rates, and Neurodevelopmental Outcomes at 18 to 22 Months

Daniel K. Benjamin, Jr, MD, MPH, PhDa, Barbara J. Stoll, MDb, Avory A. Fanaroff, MB, BChc, Scott A. McDonald, MSd, William Oh, MDe, Rosemary D. Higgins, MDf, Shahnaz Duara, MDg, Kenneth Poole, PhDd, Abbot Laptook, MDe, Ronald Goldberg, MDa on behalf of the National Institute of Child Health and Human Development Neonatal Research Network

a Department of Pediatrics, Duke Clinical Research Institute, Duke University, Durham, North Carolina
b Department of Pediatrics, Emory University, Atlanta, Georgia
c Case Western Reserve University, Rainbow Babies and Children's Hospital, Cleveland, Ohio
d Research Triangle Institute, Research Triangle Park, North Carolina
e Brown University, Rhode Island Hospital, Providence, Rhode Island
f National Institute of Child Health and Human Development, Bethesda, Maryland
g University of Miami, Jackson Memorial Hospital, Miami, Florida

BACKGROUND. Neonatal candidiasis is associated with substantial morbidity and mortality rates. Neurodevelopmental follow-up data for a large multicenter cohort have not been reported.

METHODS. Data were collected prospectively for neonates born at <1000 g at National Institute of Child Health and Human Development-sponsored Neonatal Research Network sites between September 1, 1998, and December 31, 2001. Uniform follow-up evaluations, including assessments of mental and motor development with the Bayley Scales of Infant Development II, were completed for all survivors at corrected ages of 18 to 22 months. We evaluated risk factors for the development of neonatal candidiasis, responses to antifungal therapy, and the association between candidiasis and subsequent morbidity and death.

RESULTS. The cohort consisted of 4579 infants; 320 of 4579 (7%) developed candidiasis; 307 of 320 had Candida isolated from blood, 27 of 320 had Candida isolated from cerebrospinal fluid, and 13 (48%) of 27 of those with meningitis had negative blood cultures. In multivariate analysis of risk factors on day of life 3, birth weight, cephalosporins, gender, and lack of enteral feeding were associated with development of candidiasis. After diagnosis, most neonates had multiple positive cultures despite antifungal therapy, and 10% of neonates had candidemia for ≥14 days. Death or neurodevelopmental impairment (NDI) was observed for 73% of extremely low birth weight infants who developed candidiasis. Death and NDI rates were greater for infants who had delayed removal or replacement of central catheters (>1 day after initiation of antifungal therapy), compared with infants whose catheters were removed or replaced promptly.

CONCLUSIONS. Blood cultures were negative for approximately one half of the infants with Candida meningitis. Persistent candidiasis was common. Delayed catheter removal was associated with increased death and NDI rates.

Key Words: candidiasis • meningitis • sensitivity • specificity • culture • premature infant

Abbreviations: CSF—cerebrospinal fluid • CI—confidence interval • DOL—day of life • EGA—estimated gestational age • ELBW—extremely low birth weight • IVH—intraventricular hemorrhage • NDI— neurodevelopmental impairment • MDI—Mental Developmental Index • OR—odds ratio • PDA—patent ductus arteriosus • PDI—Psychomotor Developmental Index

Accepted Mar 29, 2005.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
 Arch. Dis. Child. Fetal Neonatal Ed.Home page
A Howell, D Isaacs, R Halliday, and T. A. S. G. f. N. Infections
Oral nystatin prophylaxis and neonatal fungal infections
Arch. Dis. Child. Fetal Neonatal Ed., November 1, 2009; 94(6): F429 - F433.
[Abstract] [Full Text] [PDF]

Home page
 Arch. Dis. Child. Fetal Neonatal Ed.Home page
A Jacquot, J-M Labaune, T-P Baum, G Putet, and J-C Picaud
Rapid quantitative procalcitonin measurement to diagnose nosocomial infections in newborn infants
Arch. Dis. Child. Fetal Neonatal Ed., September 1, 2009; 94(5): F345 - F348.
[Abstract] [Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
X. Saez-Llorens, M. Macias, P. Maiya, J. Pineros, H. S. Jafri, A. Chatterjee, G. Ruiz, J. Raghavan, S. K. Bradshaw, N. A. Kartsonis, et al.
Pharmacokinetics and Safety of Caspofungin in Neonates and Infants Less than 3 Months of Age
Antimicrob. Agents Chemother., March 1, 2009; 53(3): 869 - 875.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
D. Bassler, B. J. Stoll, B. Schmidt, E. V. Asztalos, R. S. Roberts, C. M. T. Robertson, R. S. Sauve, and for the Trial of Indomethacin Prophylaxis in Prete
Using a Count of Neonatal Morbidities to Predict Poor Outcome in Extremely Low Birth Weight Infants: Added Role of Neonatal Infection
Pediatrics, January 1, 2009; 123(1): 313 - 318.
[Abstract] [Full Text] [PDF]

Home page
 Arch. Dis. Child. Fetal Neonatal Ed.Home page
M Brecht, L Clerihew, and W McGuire
Prevention and treatment of invasive fungal infection in very low birthweight infants
Arch. Dis. Child. Fetal Neonatal Ed., January 1, 2009; 94(1): F65 - F69.
[Abstract] [Full Text] [PDF]

Home page
 NeoReviewsHome page
C. M. Healy
Fungal Prophylaxis in the Neonatal Intensive Care Unit
NeoReviews, December 1, 2008; 9(12): e562 - e570.
[Abstract] [Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
R. Petraitiene, V. Petraitis, W. W. Hope, D. Mickiene, A. M. Kelaher, H. A. Murray, C. Mya-San, J. E. Hughes, M. P. Cotton, J. Bacher, et al.
Cerebrospinal Fluid and Plasma (1->3)-{beta}-D-Glucan as Surrogate Markers for Detection and Monitoring of Therapeutic Response in Experimental Hematogenous Candida Meningoencephalitis
Antimicrob. Agents Chemother., November 1, 2008; 52(11): 4121 - 4129.
[Abstract] [Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
K. C. Wade, D. Wu, D. A. Kaufman, R. M. Ward, D. K. Benjamin Jr., J. E. Sullivan, N. Ramey, B. Jayaraman, K. Hoppu, P. C. Adamson, et al.
Population Pharmacokinetics of Fluconazole in Young Infants
Antimicrob. Agents Chemother., November 1, 2008; 52(11): 4043 - 4049.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
D. Kaufman
Fluconazole Prophylaxis Decreases the Combined Outcome of Invasive Candida Infections or Mortality in Preterm Infants
Pediatrics, November 1, 2008; 122(5): 1158 - 1159.
[Full Text] [PDF]

Home page
 PediatricsHome page
C. M. Healy and C. J. Baker
Fluconazole Prophylaxis Decreases the Combined Outcome of Invasive Candida Infections or Mortality in Preterm Infants: In Reply
Pediatrics, November 1, 2008; 122(5): 1159 - 1159.
[Full Text] [PDF]

Home page
 Arch. Dis. Child. Fetal Neonatal Ed.Home page
L Clerihew and W McGuire
Antifungal prophylaxis for very low birthweight infants: UK national survey
Arch. Dis. Child. Fetal Neonatal Ed., May 1, 2008; 93(3): F238 - F239.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
C. M. Healy, J. R. Campbell, E. Zaccaria, and C. J. Baker
Fluconazole Prophylaxis in Extremely Low Birth Weight Neonates Reduces Invasive Candidiasis Mortality Rates Without Emergence of Fluconazole-Resistant Candida Species
Pediatrics, April 1, 2008; 121(4): 703 - 710.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
D. K. Benjamin Jr
First, Do No Harm
Pediatrics, April 1, 2008; 121(4): 831 - 832.
[Full Text] [PDF]

Home page
 PediatricsHome page
C. J. Ragouilliaux, S. E. Keeney, H. K. Hawkins, and J. L. Rowen
Maternal Factors in Extremely Low Birth Weight Infants Who Develop Spontaneous Intestinal Perforation
Pediatrics, December 1, 2007; 120(6): e1458 - e1464.
[Abstract] [Full Text] [PDF]

Home page
 Arch. Dis. Child. Fetal Neonatal Ed.Home page
B. A McCrossan, E. McHenry, F. O'Neill, G. Ong, and D. G Sweet
Selective fluconazole prophylaxis in high-risk babies to reduce invasive fungal infection
Arch. Dis. Child. Fetal Neonatal Ed., November 1, 2007; 92(6): F454 - F458.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
P. Manzoni, I. Stolfi, L. Pugni, L. Decembrino, C. Magnani, G. Vetrano, E. Tridapalli, G. Corona, C. Giovannozzi, D. Farina, et al.
A Multicenter, Randomized Trial of Prophylactic Fluconazole in Preterm Neonates
N. Engl. J. Med., June 14, 2007; 356(24): 2483 - 2495.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
L. A. Burwell, D. Kaufman, J. Blakely, B. J. Stoll, and S. K. Fridkin
Antifungal Prophylaxis to Prevent Neonatal Candidiasis: A Survey of Perinatal Physician Practices
Pediatrics, October 1, 2006; 118(4): e1019 - e1026.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
C. M. Cotten, S. McDonald, B. Stoll, R. N. Goldberg, K. Poole, D. K. Benjamin Jr, and on behalf of the National Institute for Child Heal
The Association of Third-Generation Cephalosporin Use and Invasive Candidiasis in Extremely Low Birth-Weight Infants
Pediatrics, August 1, 2006; 118(2): 717 - 722.
[Abstract] [Full Text] [PDF]